King Pharmaceuticals Financial Market Data
| Last Close 26-Aug-2008 |
$11.58 |
Price/ Sales Ratio |
1.51 |
| 52-Week High |
$15.78 |
Price/ Book Ratio |
1.09 |
| 52-Week Low |
$8.26 |
Price/ Earnings Ratio |
21.24 |
| 60-Month Beta |
0.4 |
Price/ Cash Flow Ratio |
4.37 |
| Market Cap (mil.) |
$2,854.3 |
Return on Assets |
3.9% |
| Shares Outstanding (mil.) |
246.5 |
Return on Equity |
5.2% |
| Dividend Rate |
-- |
Current Ratio |
4.44 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
320 |
% Owned by Institutions |
99.0% |
| Latest Short Interest Ratio |
4.39 |
Latest Net Insider Transactions |
(20,000.00) |
| Revenue Growth |
(7.6%) |
21.5% |
46.4% |
| EPS Growth |
(56.3%) |
27.9% |
1,000.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
